Herbalife (NYSE: HLF) reported Q4 EPS of $0.63, $0.02 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.19 billion.

• Reported net sales of $4.9 billion for the full year 2018, increased 10% compared to full year 2017. Fourth quarter reported net sales of $1.2 billion increased 9% compared to the prior year period.
• Record full year 2018 volume points of 5.9 billion, increased 10% compared to 20171.
• Full year 2018 reported diluted EPS of $1.98 and adjusted2 earnings of $2.88 per adjusted3 diluted share, compared to $1.29 and $2.43 respectively, for the full year 2017, which were negatively impacted by expenses of approximately $14.1 million or $0.07 per share related to the China Growth and Impact Investment Program.
• Fourth quarter reported diluted EPS of $0.34 and adjusted2 earnings of $0.63 per adjusted3 diluted share, which were negatively impacted by expenses of approximately $8.2 million or $0.04 per diluted share related to the China Growth and Impact Investment Program.
• Reiterating FY 2019 volume point guidance range of 4.0% - 8.0% growth, as well as reported and adjusted1 diluted EPS guidance of $2.34 - $2.74 and $2.70 – $3.10, respectively.
• Record worldwide sales leader retention of 67.9%.

“In 2018, we continued to show the strength of our business in providing premier nutrition products to distributors and consumers around the world. We achieved double digit net sales growth and record volume points, enhancing our value for shareholders. In 2019, our momentum will continue as global trends drive demand for our products and business opportunity, and our distributors deliver value to their customers.” - Michael O. Johnson, Chairman and CEO of Herbalife Nutrition

GUIDANCE:

Herbalife sees FY2019 EPS of $2.70-$3.10, versus the consensus of $3.20.

For earnings history and earnings-related data on Herbalife (HLF) click here.